Kanina, Aleksandra http://orcid.org/0000-0001-7753-560X
Larsson, Henrik http://orcid.org/0000-0002-6851-3297
Sjölander, Arvid
Butwicka, Agnieszka http://orcid.org/0000-0002-7247-2141
Taylor, Mark J.
Martini, Miriam I.
Lichtenstein, Paul http://orcid.org/0000-0003-3037-5287
Lundberg, Frida E.
Onofrio, Brian M. D’
Rosenqvist, Mina A. http://orcid.org/0000-0002-2788-2061
Funding for this research was provided by:
Vetenskapsrådet (2018-02119, 2018-02119)
Jeanssons Stiftelser (JS2018-0006, JS2018-0006)
Article History
Received: 20 January 2023
Revised: 19 July 2023
Accepted: 24 July 2023
First Online: 14 August 2023
Change Date: 21 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-023-02595-z
Competing interests
: Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention-deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. Henrik Larsson is editor-in-chief of JCPP Advances.